Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/13/23
End: 06/15/23
Due: 06/15/24
Phase: N/A
Priority: Normal
Start: 09/11/23
End: 08/04/24
Due: 08/04/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The Safety and Tolerability of WS016 in Healthy Chinese Volunteers | NCT06281470 | Waterstone Pharmaceutical (Wuhan) Co., LTD. | user2@example.com | None | 2023-02-13 | 2023-06-15 | 2024-06-15 | - | - | 2025-07-14 |
| A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia. | NCT06277128 | Waterstone Pharmaceutical (Wuhan) Co., LTD. | user2@example.com | None | 2023-09-11 | 2024-08-04 | 2025-08-04 | - | - | 2025-07-14 |